Veradermics, Incorporated
MANE
$103.90
-$4.23-3.91%
NYSE
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -21.85M | -5.66M | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 820.00K | 1.18M | |||
| Change in Net Operating Assets | -2.60M | 844.00K | |||
| Cash from Operations | -23.63M | -3.63M | |||
| Capital Expenditure | -5.00K | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -109.77M | -- | |||
| Cash from Investing | -109.78M | -- | |||
| Total Debt Issued | -- | -1.66M | |||
| Total Debt Repaid | -- | -845.00K | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -1.05M | -- | |||
| Issuance of Preferred Stock | 151.00M | 53.10M | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -437.00K | -283.00K | |||
| Cash from Financing | 149.51M | 50.31M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 16.11M | 46.67M | |||